Efficacy and safety of recombinant yeast-derived hepatitis B vaccines for prevention of
hepatitis B have been demonstrated unequivocally worldwide as reflected in reduction in …

Anti-HBs antibodies develop after natural infection with hepatitis B virus (HBV) or
vaccination against this virus, as a result of activation of the human immune system by the …

Trace elements play important roles in human health, but little is known about their functions
in humoral immunity. Here, we show an important role for iron in inducing cyclin E and B cell …

Background People who inject drugs (PWID) are at high risk of hepatitis B virus (HBV)
infection by sharing needles and drug use paraphernalia. In Germany, no routine …

According to international guidelines, healthcare workers and medical students immunized
against HBV are periodically tested for anti‐HB s IgG. Subjects who show an anti‐HB s titre< …

L-HBsAg is a third-generation hepatitis vaccine capable of inducing antibodies in non-
responders and thus providing potentially therapeutic treatment. In this study, L-HBsAg was …

The safety and immunogenicity profiles of currently available recombinant hepatitis B
vaccines are excellent. However, it remains a real challenge to induce protective immunity in …

Background Injection drug use is a growing major public health concern. Injection drug
users (IDUs) have a higher incidence of co-morbidities including HIV, Hepatitis, and other …

Objectives. We demonstrated the effectiveness of an accelerated hepatitis B vaccination
schedule in drug users. Methods. We compared the long-term effectiveness of accelerated …

Hepatitis B virus (HBV) vaccination has been available for over four decades. However, a
synthesis of the evidence regarding the effectiveness of this strategy on preventing hepatitis …